Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Theodore

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Annals of the New York Academy of Sciences|May 24, 2003
Inhibition of the Na,K-ATPase by the antiarrhythmic drug, BretyliumCraig Gatto, C Theodore Barkulis, William R Schneider, et al.
The New England Journal of Medicine|March 19, 1981
Adenomas of the ampulla of Vater in Gardner's syndrome--what is to be done?C Theodore, H Ronsse, J Leymarios, et al.
The Biochemical Journal|December 15, 1985
Different forms of human liver glutathione S-transferases arise from dimeric combinations of at least four immunologically and functionally distinct subunitsS V Singh, D D Dao, C A Partridge, et al.
Cancer Treatment Reports|December 1, 1987
Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinomaP Rougier, J P Droz, C Theodore, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and MabcuteS Rule, J Briones, R Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancerM Mahjoubi, J Kattan, J P Droz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1996
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferationW W Cruikshank, K Lim, A C Theodore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Immunological Investigations|November 1, 1988
Lymphocyte motility and lymphocyte chemoattractant factorsJ S Berman, W W Cruikshank, D J Beer, et al.
Leukemia & Lymphoma|June 25, 1998
Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failureL Kepka, A De Lassence, V Ribrag, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Annals of the New York Academy of Sciences|May 24, 2003
Inhibition of the Na,K-ATPase by the antiarrhythmic drug, BretyliumCraig Gatto, C Theodore Barkulis, William R Schneider, et al.
The New England Journal of Medicine|March 19, 1981
Adenomas of the ampulla of Vater in Gardner's syndrome--what is to be done?C Theodore, H Ronsse, J Leymarios, et al.
The Biochemical Journal|December 15, 1985
Different forms of human liver glutathione S-transferases arise from dimeric combinations of at least four immunologically and functionally distinct subunitsS V Singh, D D Dao, C A Partridge, et al.
Cancer Treatment Reports|December 1, 1987
Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinomaP Rougier, J P Droz, C Theodore, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and MabcuteS Rule, J Briones, R Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancerM Mahjoubi, J Kattan, J P Droz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1996
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferationW W Cruikshank, K Lim, A C Theodore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Immunological Investigations|November 1, 1988
Lymphocyte motility and lymphocyte chemoattractant factorsJ S Berman, W W Cruikshank, D J Beer, et al.
Leukemia & Lymphoma|June 25, 1998
Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failureL Kepka, A De Lassence, V Ribrag, et al.
Pageof 14